Real-world lab stories & reviews from scientists using the MACSQuant® Tyto® Family

With gentle sorting technology, hands-off operation, and a closed cartridge system, the MACSQuant Tyto Family is the preferred choice for many labs around the world.

Researchers discussing data in a lab environment equipped with a MACSQuant Tyto Lux Cell Sorter, and several MACSQuant Flow Analyzer
Researchers discussing data in a lab environment equipped with a MACSQuant Tyto Lux Cell Sorter, and several MACSQuant Flow Analyzer
Logo

Real-world lab stories & reviews from scientists using the MACSQuant® Tyto® Family

Improving operational efficiency and simplifying biosafety in core facilities

Marissa Fahlberg, PhD, Assistant Director
Flow Cytometry Core at Tulane University, New Orleans, USA

Facing increasing demands for sterility, biosafety, and application flexibility, this flow core facility adopted the MACSQuant Tyto Cell Sorter. With its closed, aerosol-free cartridge system, the team can safely process infectious samples while improving efficiency and expanding sorting capabilities.

Photo of Prof. Renzo Mancuso, who developed MIGRATE

Preparing stem cell–derived human microglia for xenotransplantation in Alzheimer's research

Renzo Mancuso, PhD, Group Leader
VIB-Center for Molecular Neurology and University of Antwerp, Belgium

This breakthrough microglia xenotransplantation protocol for Alzheimer’s research required uncompromised cells. With gentle sorting in a closed, sterile cartridge, the MACSQuant Tyto Cell Sorter was a perfect fit.

Safe sorting of innate immune cells to study infectious diseases

Rajeev Gupta, PhD, Associate Professor of Hematology
University College London Cancer Institute, London, United Kingdom

During the 2020 pandemic and after an exciting discovery, Dr. Gupta’s team focused on understanding the functional properties of innate immune cells from patients with mild and severe COVID-19. Choosing the MACSQuant Tyto Cell Sorter was essential for safe sorting of infectious samples.

Enabling the first human clinical trial with iPSC-derived dopaminergic neurons to treat Parkinson’s disease

Daisuke Doi, PhD, Assistant Professor
Center for iPS Cell Research and Application (CiRA), Kyoto, Japan

In this groundbreaking clinical trial published in Nature, Jun Takahashi’s team developed a new cell therapy for Parkinson's disease. Switching from conventional cell sorters to the MACSQuant Tyto Cell Sorter proved essential, dramatically improving cell viability and final product yield while saving time.

First in-human clinical trial for multitarget adoptive cell therapy in patients with advanced metastatic cancer

Ali Mohamed, PhD, Vice President CMC
Immatics, Houston, USA

Immatics is a clinical-stage biopharmaceutical company focusing on T cell–based cancer immunotherapies. In a pioneering clinical trial for metastatic cancer, the MACSQuant Tyto Cell Sorter was essential to isolate tumor-specific CD8⁺ T cells. These endogenous cells were expanded and successfully reinfused into the patients.

Sorting highly rare antigen-specific B cells to study infectious diseases

Patrick Wilson, PhD, Professor of Medicine, Principal Investigator
The University of Chicago, Chicago, USA

To study B cell responses in convalescent COVID-19 patients, Patrick Wilson’s team faced two major challenges: isolating extremely rare antigen-specific B cells and safely handling infectious samples. The MACSQuant Tyto Cell Sorter provided the ideal solution.

Safe sorting of infectious samples without the need for BSL-3 infrastructure

Mariane Schleimann, PhD, Project Manager, Postdoc
Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

Mariane Schleimann and colleagues are advancing a new COVID-19 therapy by isolating B cells from patients and generating virus-neutralizing antibodies. With the MACSQuant Tyto Cell Sorter, they were able to overcome biosafety limitations of conventional systems.

Preserving cell functionality for reliable single-cell genomics

Quy Nguyen, PhD
University of California, Irvine, USA

Using gentle sorting technology in a closed cartridge system, the MACSQuant Tyto Family preserves cell viability and functionality, reducing sort-induced cellular stress and enabling high-quality downstream genomic analyses.

You have previously chosen International as your location.
What do you want to do?